What is the basis for a genetic approach in neonatal disorders?
Vineet Bhandari1, Jeffrey R Gruen2
1Division of Perinatal Medicine, Department of Pediatrics, Yale University School of Medicine, New Haven, CT; Yale Child Health Research Center, Department of Pediatrics, Yale University School of Medicine, New Haven, CT.
Insights
Genetic factors influence how newborns respond to NICU treatments, impacting outcomes for conditions like bronchopulmonary dysplasia. Understanding these gene-environment interactions is key to improving neonatal care and reducing infant mortality.
Area of Science:
- Neonatal Medicine
- Genetics
- Environmental Health
Background:
- Neonatal intensive care unit (NICU) therapies have reduced mortality but not the incidence of conditions like bronchopulmonary dysplasia (BPD).
- Observed variations in treatment response suggest underlying genetic influences.
- Gene-environment interactions are proposed as a key factor in neonatal outcomes.
Purpose of the Study:
- To explore the role of gene-environment interactions in neonatal outcomes.
- To explain the persistent challenges in managing conditions like BPD despite advances in NICU care.
- To investigate how genetic factors modulate responses to neonatal interventions.
Main Methods:
- Review of existing literature on neonatal therapies and outcomes.
- Analysis of twin studies indicating heritability of BPD.
- Conceptual framework development for gene-environment interactions in neonates.
Main Results:
- Gene-environment interactions likely explain variable responses to NICU interventions (e.g., corticosteroids, ventilation, oxygen).
- Genetic factors may modulate the neonate's response to external agents, influencing injury and repair.
- Heritability of BPD supports genetic involvement, but specific interactions require further differentiation.
Conclusions:
- Gene-environment interactions are crucial for understanding and potentially improving outcomes in neonatal critical care.
- Further research is needed to distinguish between interactions with environmental toxins/pathogens and therapeutic agents.
- Personalized approaches considering genetic predispositions may enhance the efficacy of neonatal interventions.
Abstract:
Gene-environment interactions likely account for some degree of the variance in response rates that are clinically observed with antenatal corticosteroids, breast milk prophylaxis, surfactant administration, early recognition and treatment of sepsis, utility of non-invasive ventilation, and judicious exposure to supplemental oxygen. While these therapies and practice guidelines have significantly decreased overall neonatal mortality in the NICU, they have not made a marked impact on the frequency and severity of conditions such as bronchopulmonary dysplasia (BPD), necrotizing enterocolitis, and periventricular leukomalacia. One possible explanation is that genetic factors in the neonate modulate response to external intervention or preventative agents, culminating in variable levels of injury and different degrees of resolution and repair. Gene-environment explanations are supported by the observed heritability of BPD in twin studies, but they do not differentiate the interactions between neonate and offending toxin or pathogen, from interactions between neonate and intervention or therapeutic agent. Likely, both kinds of interactions are important in determining outcome.
Related Concept Videos
Behavioral Genetics and Its Designs
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Animal Mitochondrial Genetics
Incomplete Dominance


